Position in INVA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$102,059,941
-$1,308,806 QoQ
Shares Held
4,494,053
+1.3% QoQ
Ownership
6.22%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 4%
None 2%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. INVA ranks #16 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in INVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,059,941 | 4,494,053 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $103,368,747 | 4,436,427 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $87,164,414 | 4,360,401 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $79,028,940 | 4,330,353 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $86,274,353 | 4,294,393 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $84,481,990 | 4,659,790 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $85,353,634 | 4,919,518 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $90,620,399 | 4,692,926 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $76,827,339 | 4,684,594 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $70,306,050 | 4,613,258 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $72,452,661 | 4,516,999 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $57,814,643 | 4,450,704 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $53,230,582 | 4,181,507 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $42,549,793 | 3,782,204 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $42,495,318 | 3,207,194 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $34,088,338 | 2,936,119 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $39,826,550 | 2,698,276 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $49,156,623 | 2,540,394 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $43,700,149 | 2,533,342 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $42,354,753 | 2,534,695 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $33,019,751 | 2,462,323 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $27,724,693 | 2,320,058 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $29,149,048 | 2,352,627 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $24,638,665 | 2,357,767 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $32,670,155 | 2,336,921 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $26,565,992 | 2,259,013 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||